U.S. Health Care REITs Stock News

In early July 2026, Boston Scientific voluntarily recalled a single Intera Oncology INTERA 3000 Hepatic Artery Infusion Pump (Class II, Serial Number 20175) in the US after identifying potential leakage from the pump through the catheter, with the recall now classified as completed. A separate earnings update saw management cut 2026 guidance amid weakness in WATCHMAN, Electrophysiology, and Urology, while expressing confidence that upcoming product launches could support results in 2027 and...

ExxonMobil Holdings (XOM) has returned to the spotlight after US sanctions on Iranian oil exports and strikes on Iranian assets pushed crude prices higher, increasing the risk premium on energy stocks. See our latest analysis for ExxonMobil Holdings. At a latest share price of $138.88, ExxonMobil Holdings has seen a 1.03% 1 day share price gain and a 1.31% 7 day share price return, while the 30 day share price return is down 7.79% and the 90 day share price return is down 8.94%. This suggests...

Earlier this week, TechnipFMC plc announced multiple contracts from Equinor ASA for subsea tie-back developments offshore Norway and from Eni SpA for Baleine Phase 3 offshore Côte d’Ivoire, with combined awards ranging from US$325,000,000 to US$750,000,000 and booked into second-quarter 2026 inbound orders. These wins deepen TechnipFMC’s role in complex subsea production systems and flexible pipe solutions across both mature Norwegian fields and a major West African development. We’ll now...

Sun Communities (SUI) is back in focus after investors took stock of its recent share performance, with the REIT’s returns weaker over the past month and past 3 months compared with earlier periods. See our latest analysis for Sun Communities. At a share price of $118.88, Sun Communities has seen its share price return fade over recent months, with the 30 day move down 6.13% and the 90 day return down 8.06%, while the 1 year total shareholder return is down 2.02% and the 5 year total...

Recent CEO commentary on business trends and AI demand, along with research highlighting Lumentum Holdings (LITE) exposure to AI networking, has drawn fresh attention to the stock after its double digit price move. See our latest analysis for Lumentum Holdings. The recent double digit move in Lumentum Holdings comes after a 7 day share price return of 10.12% and a year to date share price return of 107.72%. This sits alongside a very large 1 year total shareholder return and an even higher 3...

Earlier this month, Kohl's announced an expanded back-to-school push, including thousands of items priced under US$25, new brands, and a partnership with YouTuber Jesser plus an AI-powered shopping assistant to better target younger and value-focused families. This campaign signals Kohl's attempt to refresh its relevance with Gen Z and budget-conscious parents at the same time it faces softer discretionary spending and pressure on in-store traffic. We'll examine how Kohl's value-led,...

Carnival has introduced Carnival Destiny, a next generation megaship and the first vessel in its new Ace Class. The ship is slated to enter service in 2029 and features an ocean facing design with extensive glass and balcony cabins. Carnival Destiny is set to include a high share of ocean view balcony cabins, 4.5 acres of glass, and more than 70% new onboard concepts. Carnival, traded as NYSE:CCL, is tying this new ship to a broader refresh of its guest offering, following its earlier...

Analyst sentiment and upcoming earnings set the tone for DNOW DNOW (DNOW) heads toward its confirmed August 5 earnings date with a current Strong Buy consensus from six analysts over the past 3 months, following its most recent earnings call on May 7. See our latest analysis for DNOW. DNOW shares trade at US$13.05 and have seen short term momentum cool, with a 30 day share price return down 5.43%, even as the 3 year total shareholder return sits at 20.50% and the 5 year total shareholder...

Innodata (INOD) is back in focus after management raised its full-year 2026 revenue growth outlook to about 40% or more, following a strong first quarter and expanding roles in key AI services. See our latest analysis for Innodata. The share price reaction around Innodata’s upgraded 2026 outlook has been mixed, with the stock down 32.13% on a 1 month share price return but still up 90.56% on a 3 month share price return and supported by a very large 3 year total shareholder return. This...

In early July 2026, Semtech Corporation entered into a new Credit Agreement establishing a US$360,000,000 revolving credit facility and an uncommitted incremental term loan option, replacing its prior JPMorgan-led facility and extending committed liquidity through July 6, 2031, subject to detailed leverage, coverage, collateral, and covenant conditions. An interesting aspect of this agreement is the leverage-based pricing grid and first-lien security package, which directly link Semtech’s...

Renewed tensions between the U.S. and Iran have pushed oil prices higher, putting Chevron (CVX) in focus as investors weigh stronger earnings prospects alongside a new 20-year power supply deal with Microsoft. See our latest analysis for Chevron. Chevron’s share price has been choppy, with a 7.06% decline over the past 30 days and a 6.44% drop over 90 days. However, the year to date share price return of 13.15% and 1 year total shareholder return of 18.34% suggest longer term momentum remains...

Advanced Micro Devices stock has surged over the past five years, yet its valuation signals are pulling in different directions, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium while market multiples still screen as supportive. Advanced Micro Devices has delivered a very large 5 year return of 549.5%, which means any new buyer is paying in the context of a long, powerful run. Heavy expectations around AI related data center growth can support the current...

FDA approved PADCEV (enfortumab vedotin-ejfv) plus Keytruda (pembrolizumab) for adult patients with muscle-invasive bladder cancer. The regimen is cleared for both neoadjuvant and adjuvant use, regardless of cisplatin eligibility. This is the first platinum-free treatment option for this indication, following results from the Phase 3 EV-304 trial. For investors tracking Pfizer (NYSE:PFE), this approval adds a fresh catalyst to an oncology portfolio that remains a core focus for the company...

In recent weeks, Bank of America has passed the Federal Reserve’s 2026 stress tests, redeemed US$2.60 billion of senior notes, and issued multiple new senior unsecured fixed‑income offerings across currencies and maturities. Together with extending large credit facilities to AI firms, exploring a purchase of Fiserv’s debit network, and activating its FIFA World Cup 2026 sponsorship, the bank is sharpening its focus on payments infrastructure, funding flexibility and brand reach across...

Mastercard (MA) is pushing deeper into AI driven payments with its Agent Pay for Machines (AP4M) platform, which connects traditional card networks to stablecoin settlement on public blockchains for autonomous software transactions. See our latest analysis for Mastercard. Against this backdrop of AI driven initiatives, Mastercard’s share price has been mixed, with a 30 day share price return of 7.70% contrasting with a year to date share price decline of 6.46%, while 5 year total shareholder...

Centrus Energy (LEU) is back in focus after finalizing a more than US$1b enrichment contract with the U.S. Department of Energy. This move shifts the company toward commercial scale HALEU production. See our latest analysis for Centrus Energy. The contract news has arrived during a rebound phase for Centrus Energy, with a 30 day share price return of 16.67% and a 7 day gain of 5.50%. However, the year to date share price return is still down 37.23% and the 1 year total shareholder return is...

Earlier this week, Wix and Elavon, a U.S. Bank subsidiary processing nearly nine billion transactions annually, launched an integrated Elavon Business Solutions and Wix offering that unifies online and in-person sales, payments, bookings, inventory and analytics for small businesses across three tiers: Launch, Grow and Scale. This tiered partnership aims to let small businesses expand without switching platforms as their needs evolve, deepening Wix’s role at the center of unified commerce...

Fresh optimism around Shake Shack (SHAK) has been triggered by expectations that the 2026 FIFA World Cup could lift foot traffic and sales, and a supportive stance from D.A. Davidson has added to the renewed interest in the stock. See our latest analysis for Shake Shack. At a share price of $58.60, Shake Shack has seen short term momentum return, with a 1 month share price return of 7.56%. However, this follows a much steeper 90 day share price decline of 40.57% and a 1 year total shareholder...

United States Antimony (UAMY) has drawn investor attention after recent trading left the stock at a last close of $6.46, with performance mixed between shorter term weakness and longer term gains. See our latest analysis for United States Antimony. Recent trading has been weak for United States Antimony, with the share price return down 2.42% over one day and 13.06% over seven days. This contrasts with a 1-year total shareholder return of 137.50%, which points to a previously strong run that...

The race to reshape obesity and diabetes treatment is moving beyond weekly injections, and Vivani Medical’s long-acting GLP-1 implant has pushed that story into the spotlight. For investors, the question is how this kind of delivery shift might affect companies tied to GLP-1 drugs, devices, and support therapies. This article looks at 3 stocks from our Obesity and Diabetes Treatment Innovation screener that appear positively exposed to the same forces driving interest in Vivani’s semaglutide...

In late April 2026, Builders FirstSource reported softer first‑quarter results amid weaker housing starts and commodity deflation, while sector-wide pressure intensified as geopolitical tensions pushed oil prices higher, stoking inflation and mortgage rate concerns that weighed on housing-related companies. At the same time, investors are watching how Builders FirstSource’s growing mix of higher-value-added products and services might cushion margins against rising input and freight costs...

Ford Motor (NYSE:F) has appointed Matt VanKuiken as Chief Government Affairs Officer. VanKuiken, a former BlackRock executive with prior government experience, will lead Ford's policy strategy and representation. The role includes engagement on issues such as USMCA and emissions standards during a key period for the automotive industry. Ford Motor enters this leadership change with its stock at $14.0 and a return of 24.7% over the past year and 38.8% over the past five years. In the shorter...

Bloom Energy stock has logged an extremely strong three year gain of about 12.9x, yet its valuation signals are split, with a Discounted Cash Flow (DCF) intrinsic value estimate suggesting the shares trade below fair value while traditional market multiples point to an expensive profile. Over the past three years, Bloom Energy has delivered a very large return of about 1,290.6%, so recent buyers are coming in after a substantial re rating. Expectations around Bloom Energy's role in powering...

Century Communities (NYSE:CCS) has opened new residential communities in Lake Havasu City, Arizona and Wilson, North Carolina. The DL Ranch and Bright Leaf projects expand the company’s presence in two growing housing markets. Both communities feature Century Communities’ online homebuying platform, allowing buyers to complete purchases digitally. Century Communities, trading at $65.04, is adding fresh product in Arizona and North Carolina at a time when investors are watching where...